RE:Epuris Sales in Mexico Thank you.
Cph received a royalty on Mexican sales.
Italmax had revenues of $142 m US in 2920, so it has some heft.
Why Epuris continues to gain market share in Canada but not in the US is the price differential.
Epuris is the best product in its niche and when it is not brand price, it will lead the market, as is obvious in Canada.
I cannot find much info on the Mexican Epuris market, so its success there too will be price driven.
interesting statement from the Q3 CC..
" We are particularly excited about the opportunities in what is typically known as the legacy asset space.
We are evaluating a number of potential products and feel that asset values and cash flow dynamics are quite compelling."